key: cord-0750802-tibxijyd authors: Shah, Vedang title: Commentary: A case of endogenous candida endophthalmitis with incidental cytomegalovirus infection and optic neuropathy in a patient recovered from severe COVID-19 date: 2022-01-03 journal: Indian J Ophthalmol DOI: 10.4103/ijo.ijo_3009_21 sha: fadc53bb041319a81418638234237e03b3c8d924 doc_id: 750802 cord_uid: tibxijyd nan given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed. Nil. There are no conflicts of interest. Endogenous endophthalmitis is a sight-threatening intraocular inflammation. Though uncommon, it accounts for 2%-16% of all endophthalmitis cases. Endogenous endophthalmitis can have devastating effects on the patient's eye and vision. Candida albicans is the most common causative pathogen isolated in these patients. However, Kaluarachchi et al. [1] in their manuscript reported the first case of microbiologically confirmed mixed viral and fungal endophthalmitis (Candida endogenous endophthalmitis and incidental CMV infection of vitreous fluid) in a patient that recovered from COVID-19 pneumonia. It is evident that Cytomegalovirus (CMV) retinitis is the most common opportunistic intraocular infection in immunocompromised patients and that mixed endogenous endophthalmitis is quite uncommon. COVID-19 pandemic has resulted in prolonged hospitalization and ICU stay with multiple indwelling catheters and intravenous lines, which is a pertinent risk factor for developing opportunistic nosocomial infections. [2] Clough et al. [3] documented a fivefold increase in the incidence of candidemia in an ICU setting during the COVID-19 pandemic. The COVID-19 infection results in substantial neutropenia along with reduction of peripheral CD4 and CD8 T cells. [4] Although systemic corticosteroids are extremely important in the management of COVID-19, they contribute to immunosuppression. [5] Ocular surface involvement due to the novel coronavirus disease 2019 (COVID-19) manifesting as ocular pain, discharge, redness, and follicular conjunctivitis has been reported in the literature. [6] Posterior segment involvement has been seen as central retinal vein occlusion, [7] and endogenous fungal endophthalmitis following severe COVID-19 disease has been noted. [8] However, ocular symptoms have been shown to poorly correlate with ophthalmic findings in patients with fungaemia. Dilated fundoscopy is a safe way to identify an uncommon but sight-threatening condition such as endophthalmitis. Bedside monitoring of vision and funduscopic examination of at-risk patients should be recommended. Confirming ophthalmic involvement will optimize the care as patients with candidemia are treated with systemic antifungal agents which have poor ocular penetrance. In the setting of ocular candida, a treatment change would be required. Endotheliopathy is an important aspect of COVID-19 disease. The SARS-COV-2 virus impacts the capillary density and perfusion of the optic nerve head, which can result in non-arteritic anterior ischemic optic neuropathy. Although vitamin K and vitamin D are administered to reduce the severity of COVID-19 disease, intervention studies are needed to assess their effects. Patients in home quarantine or those who have recovered from COVID-19 infection should be taught to monitor vision. They should be explained about the warning visual symptoms and instructed to report to their ophthalmologist if they experience any. Endogenous fungal endophthalmitis following intensive corticosteroid therapy in severe COVID-19 disease Post COVID-19 opportunistic candida retinitis: A case report. Indian J Ophthalmol Cite this article as: Shah V. Commentary: A case of endogenous candida endophthalmitis with incidental cytomegalovirus infection and optic neuropathy in a patient recovered from severe COVID-19 A case of endogenous candida endophthalmitis with incidental cytomegalovirus infection and optic neuropathy in a patient recovered from severe COVID-19 Endogenous fungal endopthalmitis treated with intravitreal caspofungin in a COVID-19 recovered patient: A case report Care for critically Ill patients with COVID-19: Don't forget the eyes SARS-CoV-2 and viral sepsis: Observations and hypotheses Dexamethasone in hospitalized patients with COVID-19 Ocular surface manifestations of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis Central retinal vein occlusion with COVID-19 infection as the presumptive etiology Endogenous fungal endophthalmitis following intensive corticosteroid therapy in severe COVID-19 disease The authors should be appreciated for prompt diagnosis and management. The combination of both systemic and topical antifungal and antiviral treatment followed by surgical intervention led to a successful outcome. As pointed out by the authors as well, we must be alert not to label such a clinical scenario as a non-infectious panuveitis and start the patient on This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.